Stem Cell Quantification In Peripheral Blood After Hyperbaric Oxygen Therapy Treatments

Status unconfirmed

Conditions studied: Changes in Peripheral Blood Population Numbers and Type.

In brief

This is an observational research study whose purposes are to see the effects of repeated hyperbaric oxygen therapy treatments on the levels of stem/progenitor cells in peripheral circulating blood following five days of treatment, 90 minutes per day at 2.0 atmospheres absolute in 100% USP Grade Oxygen. Hyperbaric oxygen has a greater oxygen concentration than air at sea level. In this research, the concentration of oxygen will be twice the level of oxygen at sea level.

Key facts

Study ID

NCT01740908

Run by

Restorix Research Institute, LLLP

People needed

8

Starts

2012-12-01

Expected to finish

2013-01-01

Last updated by the study team

2012-12-04

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Patients recruited will be healthy volunteers with no current, ongoing infection or chronic disease.

You may not qualify if…

• We will exclude or delay the treatment if our patients have an active lung infection, develops cancer, if the patient cannot undergo pressurization/ depressurization because of eustachian-tube dysfunction and confinement anxiety. Any patient that cannot breathe without a respirator will be excluded.

Where it is running

• Restorix Wound Treatment Center at Island Hospital — Anacortes, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.